-

PROLLENIUM® Expands PACE with Launch of New Digital Training Portal

New platform extends PROLLENIUM®’s clinical education program online, giving aesthetic providers centralized access to training, modules, and educational resources

RICHMOND HILL, Ontario--(BUSINESS WIRE)--PROLLENIUM®, a global leader in medical aesthetic innovation, today announced the launch of the PACE Training & Education Portal, a digital learning platform designed to expand access to the PACE (PROLLENIUM® Advanced Clinical Education) program. The portal provides aesthetic practitioners with a centralized destination for training and professional development through personalized learning pathways and gamified engagement, combining physician-led instruction with practical guidance tailored for real-world clinical settings.

PROLLENIUM® partners now have access to a comprehensive library of educational resources, including:

  • In-depth education on the PROLLENIUM® product portfolio, including Revanesse®, SoftFil, and VAMPTM, alongside holistic treatment approaches.
  • AI-powered anatomy learning tools designed to enhance understanding and support clinical confidence.
  • Clinical insights to support patient consultations and treatment planning.
  • Business development modules covering marketing strategies, social media best practices, and clinic growth optimization.
  • Access to the latest research, publications, and advancements in aesthetic medicine.
  • Exclusive integration of GEM (Global Evidence Matrix) within the Revanesse® evidence-based module, offering structured guidance on optimal injectable techniques to support safe, consistent, and predictable outcomes.

“The PACE Training & Education Portal demonstrates our commitment to providing practical clinical education for our partners to complement the high standards we hold for our products,” said Walter Geiger, PROLLENIUM®’s interim CEO. “By making expert-led, evidence-based training and resources more accessible, the portal supports continuous learning and helps practitioners refine their skills to drive subtle, predictable results for their patients.”

Extending Clinical Education Beyond the Classroom

The PACE Training & Education Portal was created to supplement PROLLENIUM®’s in-person training programs by providing practitioners with on-demand access to education and training materials. Developed in collaboration with Harley Academy, the content reflects an evidence-based approach to aesthetic education, combining physician-led instruction with practical guidance designed to support practitioners in real-world clinical settings.

A New Era of Aesthetic Education

As demand for advanced aesthetic procedures continues to grow, high-quality clinical education has become increasingly critical for providers seeking to refine their techniques and deliver consistent patient outcomes.

PACE was created by PROLLENIUM® to address this need by combining advanced technology, hands-on training, and evidence-based curriculum within a dedicated learning environment. PACE also has a strategic partnership with Harley Academy to deliver GEM, the first evidence-led injection technique training methodology.

The launch of the PACE Training & Education Portal represents the next phase of this initiative, extending PROLLENIUM®’s commitment to provider education, innovation, and clinical excellence into a scalable digital platform.

For more information, visit prollenium.com/pace

About PROLLENIUM®

Founded in 2002, PROLLENIUM® is a science-first innovator in facial aesthetics and regenerative skin technologies. PROLLENIUM® is one of the select few manufacturers to have received FDA approval for its state-of-the-art facilities and combines advanced R&D, high-quality manufacturing, and deep expertise in medical aesthetics. Aesthetic professionals trust PROLLENIUM® brands in over 70 countries.

PROLLENIUM


Release Versions

More News From PROLLENIUM

PROLLENIUM® Names Erick Brenner as Chief Executive Officer

RICHMOND HILL, Ontario--(BUSINESS WIRE)--PROLLENIUM® Medical Technologies, a privately held medical aesthetics company, has appointed Erick Brenner as Chief Executive Officer, effective immediately. Brenner succeeds Walter Geiger, who has served as Interim CEO since April 2025, and will return to his role as Operating Partner at ARCHIMED, PROLLENIUM®’s majority shareholder. Brenner most recently served as President of Galderma U.S., where he oversaw a $1.8 billion portfolio across injectable ae...

PROLLENIUM® Named Industry Partner of the Year at Aesthetic Next 2025

TORONTO--(BUSINESS WIRE)--PROLLENIUM®, a pioneer in regenerative and medical aesthetics, has been recognized as the Industry Partner of the Year at the Aesthetic Next 2025 conference. The award acknowledges PROLLENIUM®’s unwavering commitment to innovation, education, and collaborative partnership within the aesthetic community. The Industry Partner of the Year award is granted to the company that has demonstrated exceptional support and collaboration with practitioners, significantly advancing...

Prollenium Adds RENEW™+ Skin Booster to the REVANESSE® Collection

RICHMOND HILL, Ontario--(BUSINESS WIRE)--Prollenium, a global leader in medical aesthetic technology, launches Renew™+ to the Revanesse® family of dermal fillers in Canada. Available immediately, Revanesse® Renew™+ is a unique skin booster that combines low and high molecular weight hyaluronic acid (HA) to hydrate and rejuvenate the skin below the surface, improving skin texture and creating a smoother, more radiant appearance. Unlike traditional fillers, Revanesse® Renew™+ is a skin-boosting i...
Back to Newsroom